ICD10 code of Severe combined immunodeficiency and ICD9 code

Severe combined immunodeficiency (SCID) is classified under ICD-10 code D81.9 (Severe combined immunodeficiency, unspecified) and was historically categorized under ICD-9 code 279.2. These codes are essential for medical billing, clinical record-keeping, and tracking the diagnosis of this life-threatening primary immunodeficiency within global health systems.

What is the clinical significance of the ICD codes for Severe combined immunodeficiency?

The use of specific medical coding for Severe combined immunodeficiency is critical for ensuring that patients receive timely access to specialized care, such as hematopoietic stem cell transplantation (HSCT) or gene therapy. While ICD-10 D81.9 acts as a broad category, clinicians often use more granular sub-codes to define the specific molecular defect, such as D81.1 (Severe combined immunodeficiency with low T- and B-cell numbers) or D81.2 (Severe combined immunodeficiency with low or normal T- and B-cell numbers). Accurate coding helps researchers and healthcare systems monitor the prevalence of Severe combined immunodeficiency and improve diagnostic outcomes.

How is a diagnosis of Severe combined immunodeficiency confirmed?

Diagnosis of Severe combined immunodeficiency is typically initiated through newborn screening, which measures T-cell receptor excision circles (TRECs). When TREC levels are low, it triggers immediate clinical investigation. A definitive diagnosis is confirmed through a combination of:

• Flow cytometry to analyze lymphocyte subsets (T, B, and NK cell counts).


• Functional assays to measure lymphocyte proliferation in response to mitogens.


• Molecular genetic testing to identify specific mutations in genes such as IL2RG, ADA, or RAG1/2.


• Evaluation of maternal T-cell engraftment, which can sometimes mask the severity of the condition in infants.

Is Severe combined immunodeficiency hereditary?

Yes, Severe combined immunodeficiency is a genetic condition. Depending on the specific mutation, it follows different inheritance patterns. For example, X-linked Severe combined immunodeficiency (the most common form, caused by mutations in the IL2RG gene) primarily affects males. Other forms, such as those caused by Adenosine Deaminase (ADA) deficiency, are inherited in an autosomal recessive pattern. Because Severe combined immunodeficiency is a group of rare genetic disorders, genetic counseling is a vital step for families who have received a diagnosis to understand recurrence risks for future pregnancies.

What is the current outlook for those living with the condition?

Early detection is the single most important factor for improving the prognosis of Severe combined immunodeficiency. With the implementation of universal newborn screening in many countries, infants can often receive life-saving treatment before the onset of severe, life-threatening infections. At DiseaseMaps.org, we have 7 members currently sharing their experiences with Severe combined immunodeficiency, highlighting the importance of community support for families navigating the complexities of post-transplant care and long-term immunological monitoring.

Next steps

• Consult with a board-certified clinical immunologist or a specialist at a primary immunodeficiency center.


• Request genetic testing through a clinical geneticist to confirm the specific molecular subtype of your diagnosis.


• Connect with the DiseaseMaps.org community to share experiences and find peer support from others navigating rare immunodeficiencies.


• Review resources from the Immune Deficiency Foundation (IDF) for updated clinical guidelines and patient advocacy materials.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding any medical condition or treatment plan.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Severe Combined Immunodeficiency (SCID).


• Orphanet: Severe Combined Immunodeficiency (ORPHA:79275).


• OMIM (Online Mendelian Inheritance in Man): Entry #300400 (Severe Combined Immunodeficiency, X-linked).


• Immune Deficiency Foundation (IDF): Understanding Primary Immunodeficiency Diseases.